STOCK TITAN

BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

BioMarin (NASDAQ: BMRN) said its management team will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025 at 10:30 AM GMT in London, England. An audio webcast will be available live and an archived version of the remarks will be posted on the company investor website for a limited time.

Investors can access the live webcast and archive at https://investors.biomarin.com/.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+4.29% News Effect

On the day this news was published, BMRN gained 4.29%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN RAFAEL, Calif., Nov. 11, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England in London.

An audio webcast of the presentation will be available live. The webcast can be accessed at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com.

Contacts:


Investors                           

Media

Traci McCarty                   

Marni Kottle

BioMarin Pharmaceutical Inc.               

BioMarin Pharmaceutical Inc.

(415) 455-7558                                       

(650) 374-2803

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-at-the-jefferies-global-healthcare-conference-on-tuesday-november-18-2025-at-1030-am-gmt-in-london-england-302610867.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin (BMRN) present at the Jefferies Global Healthcare Conference?

BioMarin management will present on Tuesday, November 18, 2025 at 10:30 AM GMT in London.

How can I listen to the BioMarin (BMRN) presentation on November 18, 2025?

An audio webcast will be available live at https://investors.biomarin.com/.

Will BioMarin (BMRN) provide a replay of the Jefferies conference presentation?

Yes. An archived version of the remarks will be posted on the company website for a limited time after the conference.

What time is the BioMarin (BMRN) webcast for U.S. investors on November 18, 2025?

The presentation is at 10:30 AM GMT; U.S. investors should convert that to their local time zones.

Where can investors find additional details about BioMarin (BMRN) conference participation?

Details and access to the live webcast and archive are available at https://investors.biomarin.com/.
Biomarin Pharmaceutical Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Latest SEC Filings

BMRN Stock Data

11.42B
190.64M
0.78%
98.97%
3.1%
Biotechnology
Pharmaceutical Preparations
Link
United States
NOVATO